In the News | Friends of Cancer Research

You are here

In the News

June 27, 2011
By Ellen Sigal, The Food and Drug Administration has been portrayed by many critics as slow and inefficient compared with the regulatory agencies of other countries.  This criticism is of... Read more
June 16, 2011
By LISA RICHWINE The findings released on Thursday counter a common belief among doctors, academics and investors that new oncology drugs often win approval in Europe first, said researchers from... Read more
June 16, 2011
For Immediate Release - June 16,2011Contact: Ryan Hohman - 202.944.6708 or New Study Shows that FDA Approves Cancer Drugs Faster Than its European Counterpart Contrary to Repeated... Read more
June 14, 2011
By RAMSEY BAGHDADI It seems like everyone who sees the results of the CATT comparative study of Roche/Genentech’s Lucentis (ranibizumab) vs. off-label Avastin (bevacizumab) for age-related macular... Read more
June 10, 2011
ONE of the prospects supporters of the Human Genome Project held out was personalised medicine. Knowing which genes were involved in a particular patient’s disease would allow drugs to be deployed... Read more
June 6, 2011
By RON WINSLOW New research is signaling a major shift in how cancer drugs are developed and patients are treated —offering the promise of personalized therapies that reach patients faster and are... Read more
May 31, 2011
By LAURA HAMBLETON Scientists at the National Institutes of Health know Samantha Seinfeld’s body down to its cellular makeup. Every few months, she shows up at NIH’s leafy Bethesda campus to get a CT... Read more
May 27, 2011
CANCER is not one disease. It is many. Yet oncologists have long used the same blunt weapons to fight different types of cancer : cut the tumour out, zap it with radiation or blast it with... Read more
May 25, 2011
By DR. ROBERT EPSTEIN Personalized medicine has finally arrived and is poised to deliver significant health improvement and healthcare cost savings. With respect to drug therapy, genetic differences... Read more
May 24, 2011
By SHIRLEY S. WANG When former NIH head Elias Zerhouni ran the $30 billion federal research institute, he pushed for so-called translational research in which findings from basic lab research would... Read more